Back to LA Linden Advisors LP
BRBRIDGEBIO PHARMA INC
2 quarters
Position history for LALinden Advisors LP's holdings in BRIDGEBIO PHARMA INC
No. Linden Advisors exited its BRIDGEBIO PHARMA position in Q2 2026. Its Q1 2026 13F listed 132,723,000 shares worth $225.4M. Linden Advisors already held BRIDGEBIO PHARMA in its Q1 2026 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$225.4M
Total Shares Change
-132.7M
Quarter-by-Quarter History